The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down. Emerson has ...

Lykos laid off 75% of its workforce in August 2024 after the U.S. FDA declined to approve midomafetamine, an MDMA-based drug to treat PTSD. The FDA asked the company for an independent review of ...

GENEVA (AP) — Switzerland’s top criminal court on Friday convicted a multinational company for the first time, ruling against commodities trader Trafigura in a case of bribery linked to ...

A Swiss court convicted Trafigura and three people linked to the commodities trading firm of corruption in Angola, in what campaigners hailed Friday as a "historic" first in Switzerland.

Lykos Therapeutics is slashing around 75% of its staff following the FDA's decision not to approve its MDMA-assisted therapy for post-traumatic stress disorder (PTSD) last week, with founder Rick ...

Switzerland's top criminal court convicted trading house Trafigura and a former senior executive of corruption on Friday in an unprecedented case over payments made to an Angolan official in ...

Founded in 1993, Trafigura employs 13,000 people worldwide and made a net profit of almost $2.8 billion in its 2023/2024 fiscal year ending September 30. noo/gv/jj ...